SOURCE: BIOLASE Technology, Inc.

October 25, 2006 07:00 ET

BIOLASE Receives European Patent for Its Laser Pulse Technology

IRVINE, CA -- (MARKET WIRE) -- October 25, 2006 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today it has been granted a new European patent related to proprietary laser and pulse technology with claims covering key laser pulse structures, as well as soft and hard tissue applications.

President and CEO Jeffrey W. Jones said that this patent represents a significant expansion in BIOLASE's European patent position. "BIOLASE already has more than 100 patents for laser technology and its applications, with the latest being reported as recently as last month," Jones added. "This new European patent contains broad claims that cover unique and important laser pulse characteristics in our substantial laser technology portfolio. Not only does this technology drive systems such as our Waterlase® Dental Laser System, it also covers additional applications beyond dentistry and medicine and expands our intellectual property position in the European community. We remain committed to innovation that furthers our core technology and protects our market leading position in the field of laser dentistry."

The patent, No. 1 016 328 B1, was granted in Germany, Great Britain, France, Spain and Italy and contains 49 claims of which two are independent. The claims provide protection for methods and the apparatus related to pulse technologies and the circuitry that comprise lasers which operate in conjunction with fluid, gas or water, to impart disrupted forces to materials including tissues. The patent also covers key laser pulse structures responsible for fast and effective methods for using the laser on teeth, bone, cartilage and soft tissue. Some of these pulse structures are incorporated in BIOLASE products employing the Company's Er,Cr: YSGG technology. The combination of specialized laser pulses, laser wavelength and fluid output technology is one of the critical driving factors behind the Company's proprietary Waterlase technology.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (http://www.biolase.com) is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. The Company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the Waterlase® system, is one of the best selling dental laser systems. The Waterlase system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The Company also offers the LaserSmile™ system, which uses a laser to perform soft tissue and cosmetic procedures, including teeth whitening. The Company is also developing a laser for use in the field of ophthalmology.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:

    Jeffrey W. Jones,
    President & CEO

    Richard L. Harrison
    Executive Vice President and CFO

    BIOLASE Technology, Inc.
    +1-949-361-1200

    or

    Jill Bertotti
    Allen & Caron
    +1-949-474-4300